Chemoradiation Reprograms Tumor Cells and the Immune Microenvironment in Cervical Cancer
Tito A. Sandoval(Washington University in St. Louis), Julie K. Schwarz(Washington University in St. Louis)
Cited by 2
Related Papers
IRE1α–XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity
|Nature|2018|408
Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2)
|International Journal of Radiation Oncology*Biology*Physics|2016|168
AKT Inhibitors Promote Cell Death in Cervical Cancer through Disruption of mTOR Signaling and Glucose Uptake
|PLoS ONE|2014|88
Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer
|Cancer Discovery|2024|23